The most commonly used tool to diagnose TB, sputum smear microscopy, was developed in 1882 and predates the automobile. Every year sputum smear microscopy fails to detect TB in 1.8 million people, especially women, children, and people living with HIV. But in 2010 the World Health Organization endorsed a new TB diagnostic, Xpert MTB/RIF (commonly referred to as GeneXpert or Xpert). Instead of days or weeks, Xpert is able to diagnose TB in less than two hours and can detect resistance to rifampicin, identifying possible cases of MDR-TB. Watch our video to see how GeneXpert is changing Piara's fight against TB in Bangladesh.
Watch how tuberculosis changed Stefan's life and what can be done to treat this old but still deadly disease. This film is commissioned by the Dutch KNCV Tuberculosis Foundation, a national and international center of expertise for TB control and a medical development organization.
This video originally aired on Al Jazeera on the January 28th, marking the 10th Anniversary of the Global Fund to Fight Aids, TB, and Malaria. In it, the successes of the Global Fund are highlighted and RESULTS UK Executive Director Aaron Oxley talks briefly about the lasting damage not continuing to fund the Global Fund will have on these disease of poverty.
A series of public-health campaigns, including more aggressive screening, have been credited with a drop in tuberculosis cases in Kenya. The screening and treatment programme, regarded as one of the best in the developing world, is credited with taking the rate of TB infections in the East African country from a high of 116,000 in 2006 to 106,000 last year. However, this significant turnaround comes at an economic and political price. For TB screening and treatment programmes to be effective, supply chains for drugs and equipment and proper training for staff and administrative back-up must be in place.
November 14 is celebrated as Children's Day in India. Global Health Advocates India, on this day in 2011, released this documentary as part of a drive to raise awareness of the dangerous spread of TB among children. Set in North India, the film features parents of child patients and eminent TB specialist doctors, among others, discussing the scourge that is paediatric TB.
Treatment of MDR-TB costs $20,000 per patient, the high cost of treatment is denying Buenventura's sick access to healthcare. Miguel has TB and lives in Buneventura, however he received treatment too late and is resistant to first line drugs. He has to take six drugs a day. Since the end of 2010 MSF has been providing technical assistance to the National TB Program to improve diagnosis and follow-up of DR-TB patients.